PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Jun-2022 ADC Therapeutics to Present at the Jefferies Healthcare Conference Businesswire
01-Jun-2022 武田在ASCO和EHA上展示腫瘤學產品組合和研發產品線的最新研究成果 Businesswire
01-Jun-2022 武田在ASCO和EHA上展示肿瘤学产品组合和研发产品线的最新研究成果 Businesswire
01-Jun-2022 Virios Therapeutics’ Study Featured in Peer-Reviewed Journal Publication Highlighting Association of Herpes Simplex Type 1 Viral Infection with Common Gastrointestinal Disorders, Including in Patients with Comorbid Fibromyalgia Businesswire
01-Jun-2022 BELLUS Health to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference Businesswire
01-Jun-2022 Late-Breaking Data at EULAR 2022 Demonstrate Deucravacitinib Significantly Improved Disease Activity in Phase 2 PAISLEY Study in Systemic Lupus Erythematosus Businesswire
01-Jun-2022 KalVista Pharmaceuticals to Present at 13th Annual Jefferies Healthcare Conference Businesswire
01-Jun-2022 Global Pharmaceutical Logistics Market Analysis Report 2022: Robust Demand for Pharmaceutical Logistics Amid the Covid-19 Pandemic Globally - ResearchAndMarkets.com Businesswire
01-Jun-2022 Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met its Primary and All Key Secondary Endpoints Businesswire
01-Jun-2022 AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook Businesswire
01-Jun-2022 Biodesix to Present at the 42nd Annual William Blair Growth Stock Conference Businesswire
01-Jun-2022 Amanda Newton appointed to lead RWS’s Strategic Solutions Group Businesswire
01-Jun-2022 Aelis Farma Announces the Inclusion of the 1st Patient in a Phase 2b Study of AEF0117 for the Treatment of Cannabis Use Disorder (CUD) Businesswire
01-Jun-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Jun-2022 Healiva® Acquires Two Wound-healing Cell Therapy Assets From Smith+Nephew Businesswire
01-Jun-2022 Novacyt S.A.: CTDA Approval of PROmate® COVID-19 1 Gene and Grant of CE Mark for COVID-19 Lateral Flow Self-Test Businesswire
01-Jun-2022 Novacyt S.A. : Approbation par la CTDA du PROmate® COVID-19 1 Gene et octroi du marquage CE pour l'autotest de flux latéral COVID-19 Businesswire
01-Jun-2022 Noxxon to Host Key Opinion Leader Webinar on GLORIA Study Top-line Results of NOX-A12 & Radiotherapy Combination in First-line Glioblastoma Businesswire
01-Jun-2022 Sensorion Publishes Results of Combined General Meeting Resolutions Businesswire